Navigation Links
NIAID scientists to speak on range of infectious disease topics at major scientific meeting
Date:10/22/2008

Anthony S. Fauci, M.D., will speak during the opening session of ICAAC/IDSA 2008, a joint meeting of the American Society for Microbiology and the Infectious Diseases Society of America, in Washington, DC. His keynote lecture at 4:30 p.m. on Saturday, Oct. 25, is titled Global Health and Infectious Diseases: A Look to the Future. Dr. Fauci is director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

Among many global health challenges, infectious diseases remain among the most problematic, accounting for about one quarter of all deaths globally, and nearly two-thirds of deaths in sub-Saharan Africa. Dr. Fauci will discuss progress--and remaining challenges--in the fight against major infectious causes of death and disability such as HIV/AIDS, malaria, tuberculosis and drug-resistant microbes. He also will discuss how conceptual and technological progress in fields such as genomics and nanotechnology has invigorated infectious disease research. These advances also are contributing to exciting studies on the ecology of human disease, including the Human Microbiome Project, which is exploring how the billions of bacteria that inhabit our bodies contribute to health and illness.

Other NIAID scientists are scheduled to present findings during the four-day meeting as well. The range of topics covered reflects the broad scope of NIAID's research efforts aimed at better understanding, treating and preventing infectious and immune-mediated diseases.

  • Noroviruses, the highly contagious viruses that cause the episodes of acute gastroenteritis also known as winter vomiting disease (Kim Green, Ph.D.)
  • The role of gut-dwelling commensal bacteria in producing the symptoms of Crohn's disease, a chronic inflammatory disease of the intestines (Warren Strober, M.D.)
  • Antibiotic-resistant bacterial infections caused by Staphylococcus epidermidis (Michael Otto, Ph.D.) and Staphylococcus aureus (Frank DeLeo, Ph.D.)
  • Finding ways to treat primary immunodeficiencies, inherited conditions in which immune function is impaired (Steve Holland, M.D.)
  • Containing Ebola virus, for which there is currently no vaccine or specific treatment (Gary Nabel, M.D., Ph.D.)


'/>"/>

Contact: NIAID Office of Communications
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
Source:Eurekalert

Related biology news :

1. NIAID funds studies of how SARS and bird flu evade antiviral responses
2. NIAID announces 25 new awards to develop radiation countermeasures
3. AVAC comments on NIAID decision not to move forward with PAVE 100 Trial
4. NIAID announces grants to stimulate food allergy research
5. British scientists go cloud-hopping in the Pacific to improve climate predictions
6. Scientists map soils on an extinct American volcano
7. Scientists call for protected swimways for the endangered leatherback sea turtle
8. Scientists from Granada find a potential treatment to prevent diabetes and obesity
9. Scientists discover bacteria that can cause bone infections
10. Scientists propose the creation of a new type of seed bank
11. EMBO honors 59 leading life scientists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2016)... NEW YORK , December 22, 2016 ... global provider of secure solutions for the e-Government, Public Safety, HealthCare, ... a subsidiary of SuperCom, has been selected to implement and deploy ... county in Northern California , further expanding its ... ...
(Date:12/16/2016)... 16, 2016   IdentyTechSolutions America LLC , ... and solutions and a cutting-edge manufacturer of software ... is offering seamless, integrated solutions that comprise IDT ... The solutions provide IdentyTech,s customers with combined physical ... from crime and theft. "We are ...
(Date:12/15/2016)... Dec. 15, 2016   WaferGen Bio-systems, Inc. ... technology company, announced today that on December 13, 2016, ... of The Nasdaq Stock Market LLC which acknowledged that, ... of WaferGen,s common stock had been at $1.00 or ... regained compliance with Listing Rule 5550(a)(2) of the Nasdaq ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... DUBLIN , Jan 19, 2017 Research and ... has announced the addition ... - Material, Application - Forecast to 2025" report to ... The report provides a detailed analysis on current ... Market forecasts till 2025, using estimated market values as the base numbers ...
(Date:1/19/2017)... ... January 19, 2017 , ... November Research Group, LLC, ... and medical device manufacturers and regulators, is proud to announce the worldwide release ... client designed to provide product vigilance departments with the flexibility and ease of ...
(Date:1/19/2017)... Jan. 19, 2017  ArmaGen, Inc., today announced ... Ph.D., as chief executive officer, as well as ... brings to ArmaGen more than 17 years of ... development of biotherapeutics and pharmaceuticals. ... diverse experience and skillset necessary to lead ArmaGen ...
(Date:1/19/2017)... ... January 18, 2017 , ... The American ... to update its Data Sharing Policy. Specifically, the nation’s leading informatics experts, said ... to the existing policy. AMIA recommended that NIH earmark funding for researchers to ...
Breaking Biology Technology: